Telemus Capital’s Abiomed Inc ABMD Stock Holding History

Telemus Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,000	Closed	-$409K	–	404
2019 Q2	$409K	Hold	2,000	–	–	0.04%	260
2019 Q1	$571K	Sell	2,000 -36	-2%	-$12K	0.04%	265
2018 Q4	$662K	Sell	2,036 -45	-2%	-$15.6K	0.05%	228
2018 Q3	$936K	Hold	2,081	–	–	0.07%	209
2018 Q2	$851K	Hold	2,081	–	–	0.07%	226
2018 Q1	$606K	Sell	2,081 -18	-0.9%	-$4.56K	0.05%	267
2017 Q4	$394K	Buy	2,099 +99	+5%	+$18.5K	0.03%	330
2017 Q3	$337K	Hold	2,000	–	–	0.04%	259
2017 Q2	$287K	Sell	2,000 -5,000	-71%	-$672K	0.03%	302
2017 Q1	$876K	Hold	7,000	–	–	0.09%	158
2016 Q4	$789K	Sell	7,000 -4,000	-36%	-$463K	0.11%	148
2016 Q3	$1.41M	Hold	11,000	–	–	0.16%	117
2016 Q2	$1.2M	Hold	11,000	–	–	0.15%	132
2016 Q1	$1.04M	Buy	+11,000	New	+$929K	0.17%	121

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Telemus Capital's ABMD Position: Q3 2019 in Review

Telemus Capital sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 2,000 shares — an estimated $409K sold.

Telemus Capital first reported a position in ABMD in Q1 2016 and held it in 14 quarters. The position peaked at $1.41M in Q3 2016. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

Telemus Capital reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
Telemus Capital sold 2,000 Abiomed Inc shares in Q3 2019, an estimated $409K.
Telemus Capital first reported a position in Abiomed Inc in Q1 2016 and held it in 14 quarters.
Telemus Capital's Abiomed Inc position peaked at $1.41M in Q3 2016.
443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Telemus Capital's 13F filing for Q3 2019, filed 12 Nov 2019.